Situation: A 30-year-old woman with relapsing-remitting mult… | 마이메르시 MyMerci
이 문제가 수록된 문제집PLNE Question Bank 1500 문제집 보기
Nursing Practice III — Care of Clients with Problems in Surgery, Oxygenation, Fluid and Electrolytes, Infectious, Inflammatory and Immunologic Response, Cellular Aberrations
문제

Situation: A 30-year-old woman with relapsing-remitting multiple sclerosis (MS) comes to the neurology clinic. She was diagnosed 2 years ago and now takes interferon beta injections and oral baclofen for leg spasticity. She says baclofen makes her drowsy and she plans to stop taking it tomorrow. What should the nurse advise her?

해설
Drowsiness is a common adverse effect of baclofen, but stopping it abruptly can cause withdrawal with seizures, hallucinations, high fever, and rebound spasticity. The dose is changed or tapered only by the provider. Changing the timing or taking a break on her own carries the same risks.
같은 주제 다음 문제Situation: A 29-year-old woman has a pre-employment medical examination at a private manuf…이 문제가 수록된 문제집PLNE Question Bank 150014,000원 · 무료 체험 가능

심화 해설

Why abrupt baclofen discontinuation is dangerous

Baclofen is a gamma-aminobutyric acid type B (GABA-B) receptor agonist that suppresses excitatory neurotransmission in the spinal cord and brain. With regular use, the central nervous system adapts to the drug’s inhibitory tone. When the drug is removed suddenly, that inhibitory brake disappears, and the nervous system rebounds into a hyperexcitable state [1].

Abrupt withdrawal can trigger seizures, hallucinations, high fever, severe rebound spasticity, and autonomic instability. These symptoms are not merely uncomfortable; they can progress to life-threatening toxicity or withdrawal syndrome [1]. Even a relatively short interruption matters. In one multiple sclerosis patient, a 10-hour perioperative pause in oral baclofen produced severe rebound spasticity of the leg muscles [3].

Watch out! Withdrawal is not limited to intrathecal baclofen. Oral baclofen carries the same risk when stopped abruptly [1][2].

Why drowsiness does not justify self-discontinuation

Sedation is a well-known, dose-related adverse effect of baclofen. It reflects the drug’s GABA-B agonist activity in the central nervous system, not necessarily a toxic or dangerous level. The appropriate response is dose adjustment under supervision, not abrupt cessation [1].

The dose is changed or tapered only by the provider. The patient should be advised to contact the neurology provider to discuss a lower dose or alternative spasticity management rather than stopping the medication on her own [1].

Why the other options are unsafe

OptionWhy it is incorrect
1. Take the whole day’s dose at bedtimeChanging the timing or consolidating doses alters drug levels and does not eliminate withdrawal risk. It also does not address the underlying need for dose adjustment.
3. Stop for 2 days and restartEven brief interruption can precipitate rebound spasticity and withdrawal symptoms [3]. A self-directed drug holiday is unsafe.
4. Stop tomorrow because drowsiness means the dose is too highDrowsiness is a common adverse effect, not proof of toxicity. Abrupt discontinuation risks withdrawal, which can be more dangerous than the sedation itself [1].

Clinical correlation for nursing practice

Baclofen withdrawal can present with unusual symptoms. A case report described severe hyperalgesia-like pain disproportionate to expected postoperative recovery in a patient whose oral baclofen was interrupted [2]. Another report documented cardiac arrest as a rare complication of baclofen withdrawal after intrathecal pump removal . These examples reinforce that withdrawal is unpredictable and potentially catastrophic.

Key point! When a patient reports intolerable baclofen side effects, the nurse’s priority is to prevent abrupt withdrawal by facilitating prompt communication with the prescribing provider for a supervised taper or alternative therapy [1].
References (research sources)
  • [1]
    Baclofen therapeutics, toxicity, and withdrawal: A narrative review.Research articleRomito JW, Turner ER, Rosener JA, Coldiron L, Udipi A, Nohrn L (2021) · DOI: 10.1177/20503121211022197
  • [2]
    Lost in Transition: A Case Study of Oral Baclofen Withdrawal Presenting as Severe Pain.Case reportLaCroix K, Patel P, Selod O. (2026) · DOI: 10.7759/cureus.112805
  • [3]
    Intrathecal Baclofen Injection to Avoid Withdrawal in a Multiple Sclerosis Patient Undergoing Lumbar Spine Surgery: A Case Report.Case reportDupanovic M, Devine RP, Jackson SR, Lynch SG (2018) · DOI: 10.1213/XAA.0000000000000668

임상 시나리오

Baclofen Withdrawal PreventionSafe management of drowsiness in MS patients

Drowsiness is a common dose-related effect of baclofen, not a sign of toxicity. The correct response is provider-guided dose reduction or taper, never sudden self-discontinuation.

Abrupt baclofen withdrawal can cause seizures, hallucinations, high fever, autonomic instability, and rebound spasticity. Even short interruptions, such as 10 hours, may trigger severe symptoms.

Caution

Oral baclofen carries the same withdrawal risk as intrathecal baclofen. Advise the patient to contact the neurology provider before changing the dose, timing, or stopping the medication.

핵심 개념

PNLE Question Bank 1500 1,500 문제 · 로그인 없이 바로 볼 수 있어요

마이메르시로 국가고시 완벽 대비

기출문제와 상세 해설을 무료로. 내 약점을 분석하고 진도를 관리하며 더 똑똑하게 공부하세요.

무료로 시작하기

학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요.